SCHEMBL18877019

SCHEMBL18877019

c1cc(-c2nc3ccccc3nc2-c2cccc3c2sc2ccccc23)cc(-n2c3ccc4ccccc4c3c3c4ccccc4ccc32)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.37
MAPT P10636 2/20 0.32
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
NPY1R P25929 1/20 0.32
HTT P42858 1/20 0.32
NPY2R P49146 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CYP1A2 P05177 1/20 0.32
PDE10A Q9Y233 3/20 0.32
RXFP1 Q9HBX9 1/20 0.32
PRKDC P78527 5/20 0.32
PIK3CD O00329 1/20 0.31
PIK3CB P42338 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
PARP14 Q460N5 1/20 0.31
MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18877031 0.90 ALOX5 (0.38) ALOX5ALDH1A1LMNACYP1A2PRKDC
SCHEMBL18876910 0.87 ALOX5 (0.35) ALOX5MAPTALDH1A1PDE10ARXFP1
SCHEMBL21716696 0.87 ALOX5 (0.32) ALOX5
SCHEMBL18877059 0.87 LMNA (0.34) MAPTNPC1ALDH1A1LMNAHPGD
SCHEMBL18877058 0.87 MAPT (0.34) MAPTNPC1ALDH1A1LMNAHPGD
SCHEMBL18877045 0.86 CYP1A2 (0.38) MAPTNPC1ALDH1A1LMNAHPGD
SCHEMBL21213649 0.85 ALOX5 (0.36) ALOX5PDE10APRKDCPIK3CDPIK3CB
SCHEMBL21213539 0.84 ALOX5 (0.34) ALOX5PDE10APRKDCMEN1GAA
SCHEMBL17586368 0.83 MEN1 (0.32) ALOX5MAPTNPC1LMNAHPGD
SCHEMBL19655393 0.83 ALOX5 (0.33) ALOX5NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10186669-B2 Organic electroluminescent compound and an organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD (KR) 2019-01-22 US disclosed
US-9997723-B2 Organic electroluminescent compound and an organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD (KR) 2018-06-12 US disclosed
US-9997723-B2 Organic electroluminescent compound and an organic electroluminescent device comprising the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD (KR) 2018-06-12 US disclosed
US-20170279056-A1 A PLURALITY OF HOST MATERIALS AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2017-09-28 US disclosed
US-20170279056-A1 A PLURALITY OF HOST MATERIALS AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2017-09-28 US disclosed
US-20170148998-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND AN ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2017-05-25 US disclosed
US-20170148998-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND AN ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2017-05-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10186669-B2 Organic electroluminescent compound and an organic electroluminescent device comprising the same OR10J3, OPA1, ODC1 ALOX5 421/4885MAPT 636/4885NPC1 2188/4885
US-20170148998-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND AN ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME OR10J3, OPA1, ODC1 ALOX5 421/4885MAPT 636/4885NPC1 2188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.